Page last updated: 2024-09-05

ly 293111 and Inflammation

ly 293111 has been researched along with Inflammation in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adami, F; Agostini, C; Trentin, L1
Bendele, AM; Cockerham, SL; Froelich, LL; Jackson, WT; Sawyer, JS; Silbaugh, SA; Sofia, MJ; Spaethe, SM; Stengel, PW1

Reviews

1 review(s) available for ly 293111 and Inflammation

ArticleYear
Chronic obstructive pulmonary disease (COPD): new insights on the events leading to pulmonary inflammation.
    Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2003, Volume: 20, Issue:1

    Topics: Benzoates; Bronchoalveolar Lavage Fluid; CD8-Positive T-Lymphocytes; Humans; Inflammation; Pulmonary Disease, Chronic Obstructive; Smoking; Tumor Necrosis Factor-alpha

2003

Other Studies

1 other study(ies) available for ly 293111 and Inflammation

ArticleYear
Pharmacologic actions of the second generation leukotriene B4 receptor antagonist LY29311: in vivo pulmonary studies.
    Naunyn-Schmiedeberg's archives of pharmacology, 2000, Volume: 361, Issue:4

    Topics: Airway Obstruction; Animals; Benzoates; Benzopyrans; Bronchoalveolar Lavage Fluid; Calcimycin; Chemotaxis, Leukocyte; Dinoprostone; Granulocytes; Guinea Pigs; Inflammation; Leukotriene Antagonists; Leukotriene B4; Lung; Male; Receptors, Leukotriene B4; Thromboxane B2

2000